AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 66 filers reported holding AGILE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $566,000 | -78.2% | 99,225 | -73.3% | 0.02% | -77.6% |
| Q3 2016 | $2,599,000 | -6.5% | 372,326 | +1.9% | 0.08% | -15.8% |
| Q2 2016 | $2,781,000 | +19.0% | 365,416 | -2.9% | 0.10% | +18.8% |
| Q1 2016 | $2,336,000 | -38.5% | 376,196 | -3.4% | 0.08% | -35.1% |
| Q4 2015 | $3,801,000 | +189.3% | 389,486 | +99.8% | 0.13% | +219.5% |
| Q3 2015 | $1,314,000 | -13.7% | 194,894 | +10.0% | 0.04% | -4.7% |
| Q2 2015 | $1,522,000 | -9.8% | 177,150 | -2.7% | 0.04% | -10.4% |
| Q1 2015 | $1,687,000 | – | 182,020 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,123,567 | $12,104,000 | 41.30% |
| ProQuest Associates IV LLC | 5,062,363 | $28,856,000 | 8.17% |
| Vivo Capital, LLC | 1,513,975 | $8,630,000 | 2.84% |
| Aisling Capital LLC | 1,804,933 | $10,288,000 | 2.39% |
| INVESTOR AB | 3,510,189 | $20,008,000 | 1.46% |
| AlpInvest Partners B.V. | 27,693 | $158,000 | 0.56% |
| Cormorant Asset Management, LP | 563,880 | $3,214,000 | 0.43% |
| PURA VIDA INVESTMENTS, LLC | 164,501 | $938,000 | 0.34% |
| Perceptive Advisors | 661,446 | $3,770,000 | 0.27% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 140,000 | $799,000 | 0.20% |